STI-8811 drug-linker
STI-8811 drug-linker is a linker for synthesis of ADC molecule STI-8811[1].
Product Specifications
CAS Number
2833733-13-2
UNSPSC
12352211
Target
ADC Linker
Type
Reference compound
Related Pathways
Antibody-drug Conjugate/ADC Related
Applications
Cancer-programmed cell death
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/sti-8811-drug-linker.html
Smiles
BrCC1=NC2=C(C=CC(C(NCC(NCC(NCC(NCC(NCC(NC3=CC=C(C=C3)C[C@@H](CN=[N+]=[N-])NC([C@H](C)[C@H]([C@@]4([H])N(CCC4)C(C[C@@H](OC)[C@H]([C@@H](C)CC)N(C)C([C@H](C(C)C)NC([C@@H](N(C)C)C(C)C)=O)=O)=O)OC)=O)=O)=O)=O)=O)=O)=O)=C2)N=C1CBr
Molecular Formula
C61H90Br2N16O12
Molecular Weight
1399.28
References & Citations
[1]Springer AD, et al., Preclinical Evaluation of STI-8811, a Novel Antibody-Drug Conjugate Targeting BCMA for the Treatment of Multiple Myeloma. Cancer Res Commun. 2024 Oct 1;4 (10) :2660-2672.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
BNC882959-100 1x 100 µL
Cytokeratin 15 (Esophageal Squamous Cell Carcinoma Marker) (KRT15/2959), CF488A conjugate, 0.1mg/mL
Sign In for Pricing
View Details